1. Conroy S, McIntyre J, Choonara I (1999) Unlicensed and off-label drug use in neonates. Arch Dis Child Neonatal Ed 80:F142–F145
2. Sammons H (2006) Ethical considerations for clinical trials on medicinal products with the paediatric population. Recommendations of the ad hoc group for the development of implementing guidelines for Directive 2001/20/EC relating to good clinical practice in the conduct of clinical trials on medicinal products for human use. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-10/ethical_considerations.pdf .
3. Sutherland J (1959) Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. Am J Dis Child 18:761–767
4. Silverman W et al (1956) A different mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 18:614–621
5. Committee for Medicinal Products for Human Use (2007) Guideline on the investigation of medicinal products in the term and preterm neonate. http://www.emea.europa.eu